(Q36571864)

15 August 2017

1 reference

title

Animal models of malignant mesothelioma (English)

1 reference

15 August 2017

Agnes B Kane

1

1 reference

15 August 2017

1 November 2006

1 reference

15 August 2017

Inhalation Toxicology

1 reference

15 August 2017

18

1 reference

15 August 2017

1001-1004

1 reference

15 August 2017

12

1 reference

A mouse model recapitulating molecular features of human mesothelioma

15 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

SV40 and human tumours: myth, association or causality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Mouse models of human cancer as tools in drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

What have animal models taught us about the p53 pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Mouse models incorporating alterations in the major tumor suppressor genes P53 and P16: their use in screening for potential carcinogens, developing further relevant mouse models, and screening for potential chemopreventive and chemotherapetutic age

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Diseases caused by asbestos: mechanisms of injury and disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Neurofibromatosis type II: mouse models reveal broad roles in tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

PI3K-Akt pathway: its functions and alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

Epidemiology, biologic behavior, and natural history of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370600835393

10.1080/08958370600835393

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16920675